Outbreak of Shiga toxin-producing Escherichia-coli-associated hemolytic uremic syndrome in Istanbul in 2015: outcome and experience with eculizumab.

MLA

Ağbaş, Ayşe, et al. “Outbreak of Shiga Toxin-Producing Escherichia-Coli-Associated Hemolytic Uremic Syndrome in Istanbul in 2015: Outcome and Experience with Eculizumab.” Pediatric Nephrology (Berlin, Germany), vol. 33, no. 12, Dec. 2018, pp. 2371–81. EBSCOhost, https://doi.org/10.1007/s00467-018-4033-0.

APA

Ağbaş, A., Göknar, N., Akıncı, N., Yıldırım, Z. Y., Taşdemir, M., Benzer, M., Gökçe, İ., Candan, C., Küçük, N., Uzuner, S., Özçelik, G., Demirkol, D., Sever, L., & Çalışkan, S. (2018). Outbreak of Shiga toxin-producing Escherichia-coli-associated hemolytic uremic syndrome in Istanbul in 2015: outcome and experience with eculizumab. Pediatric Nephrology (Berlin, Germany), 33(12), 2371–2381. https://doi.org/10.1007/s00467-018-4033-0

Chicago

Ağbaş, Ayşe, Nilüfer Göknar, Nurver Akıncı, Zeynep Yürük Yıldırım, Mehmet Taşdemir, Meryem Benzer, İbrahim Gökçe, et al. 2018. “Outbreak of Shiga Toxin-Producing Escherichia-Coli-Associated Hemolytic Uremic Syndrome in Istanbul in 2015: Outcome and Experience with Eculizumab.” Pediatric Nephrology (Berlin, Germany) 33 (12): 2371–81. doi:10.1007/s00467-018-4033-0.